Marco Pistis - Publications

Affiliations: 
Dept Neuroscience, Univ Cagliari, Cagliari, Sardegna, Italy 
Area:
Neurosciences

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Congiu M, Trusel M, Pistis M, Mameli M, Lecca S. Opposite responses to aversive stimuli in lateral habenula neurons. The European Journal of Neuroscience. PMID 30860301 DOI: 10.1111/ejn.14400  0.88
2018 De Felice M, Melis M, Aroni S, Muntoni AL, Fanni S, Frau R, Devoto P, Pistis M. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics. PMID 30461214 DOI: 10.1111/cns.13087  1
2018 Sagheddu C, Scherma M, Congiu M, Fadda P, Carta G, Banni S, Wood JT, Makriyannis A, Malamas MS, Pistis M. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward. Neuropharmacology. 144: 327-336. PMID 30439418 DOI: 10.1016/j.neuropharm.2018.11.013  0.8
2018 Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, et al. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology. PMID 30151725 DOI: 10.1007/s12035-018-1319-y  1
2017 Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. PMID 28766701 DOI: 10.1111/epi.13863  1
2016 Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 110: 251-259. PMID 27457507 DOI: 10.1016/j.neuropharm.2016.07.024  1
2016 Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal immune activation disrupts dopamine system in the offspring. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26819283 DOI: 10.1093/ijnp/pyw007  1
2016 Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology. PMID 26728894 DOI: 10.1007/s00213-015-4196-3  1
2015 Sagheddu C, Muntoni AL, Pistis M, Melis M. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. International Review of Neurobiology. 125: 257-302. PMID 26638769 DOI: 10.1016/bs.irn.2015.10.004  1
2015 Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26388146 DOI: 10.1038/npp.2015.295  1
2015 Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology. 97: 383-93. PMID 26113399 DOI: 10.1016/j.neuropharm.2015.06.003  1
2015 Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, ... ... Pistis M, et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience. 18: 75-86. PMID 25485758 DOI: 10.1038/nn.3892  1
2014 Melis M, Sagheddu C, De Felice M, Casti A, Madeddu C, Spiga S, Muntoni AL, Mackie K, Marsicano G, Colombo G, Castelli MP, Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12716-24. PMID 25232109 DOI: 10.1523/JNEUROSCI.1844-14.2014  1
2014 Melis M, Pistis M. Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 86: 42-9. PMID 24704146 DOI: 10.1016/j.phrs.2014.03.009  1
2013 Melis M, De Felice M, Lecca S, Fattore L, Pistis M. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Frontiers in Integrative Neuroscience. 7: 93. PMID 24416004 DOI: 10.3389/fnint.2013.00093  1
2013 Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, et al. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nature Neuroscience. 16: 1652-61. PMID 24121737 DOI: 10.1038/nn.3540  1
2013 Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, Scheggi S, Carta G, Murru E, Aroni S, Muntoni AL, Pistis M. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. Plos One. 8: e64541. PMID 23724059 DOI: 10.1371/journal.pone.0064541  1
2013 Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, ... ... Pistis M, et al. PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6203-11. PMID 23554501 DOI: 10.1523/JNEUROSCI.4647-12.2013  1
2013 Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. Cns & Neurological Disorders Drug Targets. 12: 70-7. PMID 23394525 DOI: 10.2174/1871527311312010012  1
2013 Costa M, Squassina A, Congiu D, Chillotti C, Niola P, Galderisi S, Pistis M, Del Zompo M. Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 749-59. PMID 22920733 DOI: 10.1016/j.euroneuro.2012.07.007  1
2012 Melis M, Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3276-85. PMID 23108546 DOI: 10.1098/rstb.2011.0383  1
2012 Barrot M, Sesack SR, Georges F, Pistis M, Hong S, Jhou TC. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 14094-101. PMID 23055478 DOI: 10.1523/JNEUROSCI.3370-12.2012  1
2012 Luchicchi A, Pistis M. Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. Molecular Neurobiology. 46: 374-92. PMID 22801993 DOI: 10.1007/s12035-012-8299-0  1
2012 Panlilio LV, Justinova Z, Mascia P, Pistis M, Luchicchi A, Lecca S, Barnes C, Redhi GH, Adair J, Heishman SJ, Yasar S, Aliczki M, Haller J, Goldberg SR. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1838-47. PMID 22453137 DOI: 10.1038/npp.2012.31  1
2012 Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Frontiers in Pharmacology. 3: 7. PMID 22347186 DOI: 10.3389/fphar.2012.00007  1
2012 Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1164-76. PMID 22169942 DOI: 10.1038/npp.2011.302  1
2011 Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 589-602. PMID 21048703 DOI: 10.1038/npp.2010.190  1
2011 Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, et al. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biological Psychiatry. 69: 633-41. PMID 20801430 DOI: 10.1016/j.biopsych.2010.07.009  1
2010 Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biological Psychiatry. 68: 256-64. PMID 20570248 DOI: 10.1016/j.biopsych.2010.04.016  1
2010 Luchicchi A, Lecca S, Carta S, Pillolla G, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. Addiction Biology. 15: 277-88. PMID 20477753 DOI: 10.1111/j.1369-1600.2010.00222.x  1
2010 Fattore L, Melis M, Fadda P, Pistis M, Fratta W. The endocannabinoid system and nondrug rewarding behaviours. Experimental Neurology. 224: 23-36. PMID 20353776 DOI: 10.1016/j.expneurol.2010.03.020  1
2010 Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Current Medicinal Chemistry. 17: 1450-67. PMID 20166922 DOI: 10.2174/092986710790980014  1
2009 Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology. 201: 471-81. PMID 18777018 DOI: 10.1007/s00213-008-1309-2  1
2008 Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13985-94. PMID 19091987 DOI: 10.1523/JNEUROSCI.3221-08.2008  1
2008 Fattore L, Fadda P, Spano MS, Pistis M, Fratta W. Neurobiological mechanisms of cannabinoid addiction. Molecular and Cellular Endocrinology. 286: S97-S107. PMID 18372102 DOI: 10.1016/j.mce.2008.02.006  1
2008 Perra S, Pillolla G, Luchicchi A, Pistis M. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system. Alcoholism, Clinical and Experimental Research. 32: 443-9. PMID 18215217 DOI: 10.1111/j.1530-0277.2007.00588.x  1
2007 Melis M, Pistis M. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Current Neuropharmacology. 5: 268-77. PMID 19305743 DOI: 10.2174/157015907782793612  1
2007 Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. European Journal of Pharmacology. 573: 11-9. PMID 17644084 DOI: 10.1016/j.ejphar.2007.06.047  1
2007 Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology. 191: 843-53. PMID 17334799 DOI: 10.1007/s00213-007-0733-z  1
2006 Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiology of Disease. 24: 15-27. PMID 16762556 DOI: 10.1016/j.nbd.2006.04.010  1
2006 Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. The European Journal of Neuroscience. 23: 2385-94. PMID 16706846 DOI: 10.1111/j.1460-9568.2006.04759.x  1
2005 Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology. 183: 368-77. PMID 16228194 DOI: 10.1007/s00213-005-0195-0  1
2005 Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience. 131: 465-74. PMID 15708487 DOI: 10.1016/j.neuroscience.2004.11.021  1
2004 Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10707-15. PMID 15564588 DOI: 10.1523/JNEUROSCI.3502-04.2004  1
2004 Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 56: 86-94. PMID 15231440 DOI: 10.1016/j.biopsych.2004.05.006  1
2004 Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 53-62. PMID 14715937 DOI: 10.1523/JNEUROSCI.4503-03.2004  1
2004 Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 46: 115-25. PMID 14654103 DOI: 10.1016/j.neuropharm.2003.08.003  1
2003 Sanna A, Congeddu E, Porcella A, Saba L, Pistis M, Peis M, Marchese G, Ruiu S, Lobina C, Grayson DR, Gessa GL, Pani L. Characterization of wild-type (R100R) and mutated (Q100Q) GABAA alpha 6 subunit in Sardinian alcohol non-preferring rats (sNP). Brain Research. 967: 98-105. PMID 12650970 DOI: 10.1016/S0006-8993(02)04230-0  1
2002 Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Research. 948: 155-8. PMID 12383968 DOI: 10.1016/S0006-8993(02)03055-X  1
2002 Castelli MP, Mocci I, Pistis M, Peis M, Berta D, Gelain A, Gessa GL, Cignarella G. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. European Journal of Pharmacology. 446: 1-5. PMID 12098579 DOI: 10.1016/S0014-2999(02)01713-2  1
2002 Pistis M, Muntoni AL, Pillolla G, Gessa GL. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. The European Journal of Neuroscience. 15: 1795-802. PMID 12081659 DOI: 10.1046/j.1460-9568.2002.02019.x  1
2001 Pistis M, Porcu G, Melis M, Diana M, Gessa GL. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. The European Journal of Neuroscience. 14: 96-102. PMID 11488953 DOI: 10.1046/j.0953-816X.2001.01612.x  1
2001 Saba L, Porcella A, Congeddu E, Colombo G, Peis M, Pistis M, Gessa GL, Pani L. The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line. Brain Research. Molecular Brain Research. 87: 263-70. PMID 11245930 DOI: 10.1016/S0169-328X(01)00003-1  1
2000 Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 642-9. PMID 10788763 DOI: 10.1016/S0893-133X(00)00087-7  1
1999 Belelli D, Pistis M, Peters JA, Lambert JJ. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends in Pharmacological Sciences. 20: 496-502. PMID 10603492 DOI: 10.1016/S0165-6147(99)01405-4  1
1999 Belelli D, Pistis M, Peters JA, Lambert JJ. The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors. Neurochemistry International. 34: 447-52. PMID 10397373 DOI: 10.1016/S0197-0186(99)00037-6  1
1999 Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. The European Journal of Neuroscience. 11: 1037-41. PMID 10103095 DOI: 10.1046/j.1460-9568.1999.00488.x  1
1999 Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature. 397: 359-63. PMID 9950429 DOI: 10.1038/16941  1
1999 Pistis M, Belelli D, McGurk K, Peters JA, Lambert JJ. Complementary regulation of anaesthetic activation of human (alpha6beta3gamma2L) and Drosophila (RDL) GABA receptors by a single amino acid residue. The Journal of Physiology. 515: 3-18. PMID 9925873  1
1998 McGurk KA, Pistis M, Belelli D, Hope AG, Lambert JJ. The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor. British Journal of Pharmacology. 124: 13-20. PMID 9630337 DOI: 10.1038/sj.bjp.0701787  1
1997 Pistis M, Belelli D, Peters JA, Lambert JJ. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. British Journal of Pharmacology. 122: 1707-19. PMID 9422818 DOI: 10.1038/sj.bjp.0701563  1
1997 Pistis M, Muntoni AL, Gessa G, Diana M. Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience. 79: 171-6. PMID 9178873 DOI: 10.1016/S0306-4522(96)00643-4  1
1996 Diana M, Pistis M, Muntoni A, Gessa G. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neuroscience. 71: 411-5. PMID 9053796 DOI: 10.1016/0306-4522(95)00482-3  1
1996 Diana M, Muntoni AL, Pistis M, Collu M, Forgione A, Gessa GL. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity. European Journal of Pharmacology. 312: 179-81. PMID 8894593 DOI: 10.1016/0014-2999(96)00581-X  1
1995 Diana M, Pistis M, Muntoni A, Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. The Journal of Pharmacology and Experimental Therapeutics. 272: 781-5. PMID 7853194  1
1995 Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse (New York, N.Y.). 20: 153-5. PMID 7570345 DOI: 10.1002/syn.890200209  1
1995 Diana M, Pistis M, Muntoni AL, Gessa GL. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system. Brain Research. 682: 29-34. PMID 7552323 DOI: 10.1016/0006-8993(95)00292-X  1
1993 Diana M, Pistis M, Muntoni A, Gessa G. Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration. European Journal of Pharmacology. 230: 363-5. PMID 8440312 DOI: 10.1016/0014-2999(93)90574-2  1
1993 Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proceedings of the National Academy of Sciences of the United States of America. 90: 7966-9. PMID 8367449  1
1992 Diana M, Pistis M, Muntoni A, Rossetti ZL, Gessa G. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats. European Journal of Pharmacology. 221: 403-4. PMID 1426019 DOI: 10.1016/0014-2999(92)90734-L  1
1992 Diana M, Pistis M, Muntoni A, Gessa GL. Electrophysiological effects of acute and chronic ethanol administration Pharmacological Research. 26: 216.  1
Show low-probability matches.